|
1
|
Rini BI, Campbell SC and Escudier B: Renal
cell carcinoma. Lancet. 373:1119–1132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang WB, Pan ZQ, Yang QS and Zheng XM:
Tumor suppressive miR-509-5p contributes to cell migration,
proliferation and antiapoptosis in renal cell carcinoma. Ir J Med
Sci. 182:621–627. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Redova M, Poprach A, Besse A, Iliev R,
Nekvindova J, Lakomy R, Radova L, Svoboda M, Dolezel J, Vyzula R
and Slaby O: MiR-210 expression in tumor tissue and in vitro
effects of its silencing in renal cell carcinoma. Tumour Biol.
34:481–491. 2013. View Article : Google Scholar
|
|
5
|
Baldinu P, Cossu A, Manca A, Satta MP,
Sini MC, Rozzo C, Dessole S, Cherchi P, Gianfrancesco F, Pintus A,
et al: Identification of a novel candidate gene, CASC2, in a region
of common allelic loss at chromosome 10q26 in human endometrial
cancer. Hum Mutat. 23:318–326. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Baldinu P, Cossu A, Manca A, Satta MP,
Sini MC, Palomba G, Dessole S, Cherchi P, Mara L, Tanda F and
Palmieri G: CASC2a gene is down-regulated in endometrial cancer.
Anticancer Res. 27:235–243. 2007.PubMed/NCBI
|
|
7
|
Wang P, Liu YH, Yao YL, Li Z, Li ZQ, Ma J
and Xue YX: Long non-coding RNA CASC2 suppresses malignancy in
human gliomas by miR-21. Cell Signal. 27:275–282. 2015. View Article : Google Scholar
|
|
8
|
Yu Z, Chen D, Su Z, Li Y, Yu W, Zhang Q,
Yang L, Li C, Yang S, Ni L, et al: MiR-886-3p upregulation in clear
cell renal cell carcinoma regulates cell migration, proliferation
and apoptosis by targeting PITX1. Int J Mol Med. 34:1409–1416.
2014.PubMed/NCBI
|
|
9
|
Ha TY: MicroRNAs in human diseases: From
cancer to cardiovascular disease. Immune Netw. 11:135–154. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Paraskevopoulou MD, Georgakilas G,
Kostoulas N, Reczko M, Maragkakis M, Dalamagas TM and Hatzigeorgiou
AG: DIANA-LncBase: Experimentally verified and computationally
predicted microRNA targets on long non-coding RNAs. Nucleic Acids
Res. 41(Database Issue): D239–D245. 2013. View Article : Google Scholar :
|
|
11
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee
DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cesana M, Cacchiarelli D, Legnini I,
Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I: A
long noncoding RNA controls muscle differentiation by functioning
as a competing endogenous RNA. Cell. 147:358–369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB,
Yin DD, Kong R, Xia R, Lu KH, Li JH, et al: Lnc RNA HOTAIR
functions as a competing endogenous RNA to regulate HER2 expression
by sponging miR-331-3p in gastric cancer. Mol Cancer. 13:922014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qiao HP, Gao WS, Huo JX and Yang ZS: Long
non-coding RNA GAS5 functions as a tumor suppressor in renal cell
carcinoma. Asian Pac J Cancer Prev. 14:1077–1082. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Y and Wang X: Role of long noncoding
RNAs in malignant disease (Review). Mol Med Rep. 13:1463–1469.
2016.
|
|
17
|
Salameh A, Lee AK, Cardó-Vila M, Nunes DN,
Efstathiou E, Staquicini FI, Dobroff AS, Marchiò S, Navone NM,
Hosoya H, et al: PRUNE2 is a human prostate cancer suppressor
regulated by the intronic long noncoding RNA PCA3. Proc Natl Acad
Sci USA. 112:8403–8408. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z,
Deng X, Chen H, Shen B, Peng C, et al: Upregulation of long
noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor
prognosis in hepatocellular carcinoma. Oncogene. 35:1575–1584.
2016. View Article : Google Scholar
|
|
19
|
Liang WC, Fu WM, Wong CW, Wang Y, Wang WM,
Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF and Waye MM: The lncRNA
H19 promotes epithelial to mesenchymal transition by functioning as
miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hirata H, Hinoda Y, Shahryari V, Deng G,
Nakajima K, Tabatabai ZL, Ishii N and Dahiya R: Long noncoding RNA
MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and
interacts with miR-205. Cancer Res. 75:1322–1331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Song S, Wu Z, Wang C, Liu B, Ye X, Chen J,
Yang Q, Ye H, Xu B and Wang L: RCCRT1 is correlated with prognosis
and promotes cell migration and invasion in renal cell carcinoma.
Urology. 84:730.e1–e7. 2014. View Article : Google Scholar
|
|
22
|
Wang L, Cai Y, Zhao X, Jia X, Zhang J, Liu
J, Zhen H, Wang T, Tang X, Liu Y and Wang J: Down-regulated long
non-coding RNA H19 inhibits carcinogenesis of renal cell carcinoma.
Neoplasma. 62:412–418. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lv L, Huang F, Mao H, Li M, Li X, Yang M
and Yu X: MicroRNA-21 is overexpressed in renal cell carcinoma. Int
J Biol Markers. 28:201–207. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li X, Xin S, He Z, Che X, Wang J, Xiao X,
Chen J and Song X: MicroRNA-21 (miR-21) post-transcriptionally
downregulates tumor suppressor PDCD4 and promotes cell
transformation, proliferation and metastasis in renal cell
carcinoma. Cell Physiol Biochem. 33:1631–1642. 2014. View Article : Google Scholar
|
|
25
|
Bera A, Ghosh-Choudhury N, Dey N, Das F,
Kasinath BS, Abboud HE and Choudhury GG: NFκB-mediated cyclin D1
expression by microRNA-21 influences renal cancer cell
proliferation. Cell Signal. 25:2575–2586. 2013. View Article : Google Scholar : PubMed/NCBI
|
